glutarylphenylalanine-4-nitroanilide: substrate for Streptomyces griseus protease 3
ID Source | ID |
---|---|
PubMed CID | 111098 |
SCHEMBL ID | 14419882 |
MeSH ID | M0051312 |
Synonym |
---|
5-({(2s)-1-[(4-nitrophenyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-5-oxopentanoic acid |
n-glutaryl-l-phenylalanine p-nitroanilide, protease substrate |
5800-34-0 |
5-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid |
(s)-5-((1-benzyl-2-((4-nitrophenyl)amino)-2-oxoethyl)amino)-5-oxovaleric acid |
glutaryl-phe-p-nitroanilide |
glutarylphenylalanine-p-nitroanilide |
glutarylphenylalanine-4-nitroanilide |
einecs 227-351-4 |
glutaryl-l-phenylalanine-p-nitroanilide |
n-glutaryl-l-phenylalanine p-nitroanilide |
glutaryl-l-phenylalanine 4-nitroanilide |
SCHEMBL14419882 |
glutaryl-phe-pna |
mfcd00038362 |
AKOS030555231 |
(s)-5-(1-(4-nitrophenylamino)-1-oxo-3-phenylpropan-2-ylamino)-5-oxopentanoic acid |
F10944 |
AS-46929 |
5-hydroxy-5-{[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]imino}pentanoic acid |
DTXSID30973571 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.27) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (8.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |